Medicare Part D Will Cover Wegovy Starting July 1, 2026 — Are You Eligible?
Starting July 1, 2026, Medicare Part D — and Medicare Advantage plans with Part D benefits — will cover Wegovy® specifically for chronic weight management for the first time. Previously, Medicare covered Wegovy® only for cardiovascular risk reduction. This expansion means millions of additional beneficiaries may now qualify for GLP-1 weight loss coverage at just $50 per month. What Is the Medicare GLP-1 Bridge Program? The Medicare GLP-1 Bridge Program is a new federal coverage expansion that takes effect July 1, 2026. Under this program, Medicare Part D plans are required to cover Wegovy® (semaglutide 2.4mg) for eligible beneficiaries at a capped cost of $50 per month . This is a historic shift. Previously Medicare explicitly excluded weight loss medications from coverage. The GLP-1 Bridge Program changes that permanently. Who Is Eligible? To qualify for Medicare GLP-1 coverage you must meet ALL of the following: ✅ Enrolled in Medicare Part D OR Medicare Advantage plan with Part D ben...
